| Literature DB >> 24966076 |
Richard Lemal1, Olivier Tournilhac1, Jacques-Olivier Bay1.
Abstract
Haematological malignancies comprise a wide spectrum of well-defined entities, and require a risk-adapted treatment. Beside the classical diagnostic tools, haematologists have routinely access to more and more biological markers, which provide different informations about diagnosis, prognosis and targetable status of each individual disease and permit to define a personalized risk-adapted therapeutic strategy. We aim to describe these different biological markers and to pinpoint their accurate role in daily practice.Entities:
Keywords: biology; diagnosis; haematology; prognosis
Mesh:
Substances:
Year: 2014 PMID: 24966076 DOI: 10.1684/bdc.2014.1974
Source DB: PubMed Journal: Bull Cancer ISSN: 0007-4551 Impact factor: 1.276